phenylpropanolamine has been researched along with Weight Loss in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, HT; Lasoff, D; Minns, A | 1 |
| Blüher, M; Chen-Stute, A; Hastreiter, L; Hauner, H; Scholze, J; Werdier, D | 1 |
| Gutierrez, R; Hoyo-Vadillo, C; Kalyanasundar, B; Perez, CI; Simon, SA; Solorio, J | 1 |
| Andrews, C; Netemeyer, RG; Whisenhunt, BL; Williamson, DA | 1 |
| CAMPBELL, KD; EHRMANTRAUT, WR; FAZEKAS, JF; NEGRON, MC | 1 |
| Mittleman, G; Rushing, PA; Winders, SE | 1 |
| Alger, S; Boyce, VL; Ferraro, RT; Fontvieille, AM; Larson, K; Ravussin, E; Rising, R; Seagle, H | 1 |
| Greenway, F; Herber, D; Morales, S; Raum, W | 1 |
| Bray, GA; Greenway, FL; Marlin, RL | 1 |
| Ryan, DH | 1 |
| Echard, BW; Manohar, V; Preuss, HG; Talpur, NA | 1 |
| Borovicka, MC; Fuller, MA; Jaskiw, GE; Konicki, PE; Steele, VM; White, JC | 1 |
| Schteingart, DE | 1 |
| Greenway, FL | 1 |
| Winick, C | 1 |
2 review(s) available for phenylpropanolamine and Weight Loss
| Article | Year |
|---|---|
Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Dexfenfluramine; Dextroamphetamine; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phenylpropanolamine; Serotonin Agents; Weight Loss | 2000 |
Clinical studies with phenylpropanolamine: a metaanalysis.
Topics: Appetite Depressants; Benzocaine; Drug Therapy, Combination; Humans; Meta-Analysis as Topic; Obesity; Phenylpropanolamine; Weight Loss | 1992 |
6 trial(s) available for phenylpropanolamine and Weight Loss
| Article | Year |
|---|---|
Efficacy and Safety of Cathine (Nor-Pseudoephedrine) in the Treatment of Obesity: A Randomized Dose-Finding Study.
Topics: Adult; Anti-Obesity Agents; Body Mass Index; Body Weight; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Obesity; Overweight; Phenylpropanolamine; Placebos; Weight Loss | 2017 |
Effect of phenylpropanolamine on energy expenditure and weight loss in overweight women.
Topics: Adolescent; Adult; Basal Metabolism; Blood Pressure; Body Composition; Catecholamines; Double-Blind Method; Energy Metabolism; Female; Humans; Middle Aged; Nitrogen; Phenylpropanolamine; Placebos; Weight Loss | 1993 |
Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
Topics: Adolescent; Adult; Aged; Appetite Depressants; Benzocaine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Ephedrine; Female; Humans; Male; Middle Aged; Nonprescription Drugs; Obesity; Phenylpropanolamine; Weight Loss | 1999 |
Methods to maximize retention in weight loss studies.
Topics: Appetite Depressants; Double-Blind Method; Humans; Mazindol; Patient Dropouts; Patient Selection; Phenylpropanolamine; Placebos; Weight Loss | 1999 |
Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Appetite Depressants; Clozapine; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Obesity; Phenylpropanolamine; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Research Design; Schizophrenia; Treatment Outcome; Weight Gain; Weight Loss | 2002 |
Effectiveness of phenylpropanolamine in the management of moderate obesity.
Topics: Adult; Blood Pressure; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; Female; Humans; Male; Middle Aged; Obesity; Phenylpropanolamine; Weight Loss | 1992 |
7 other study(ies) available for phenylpropanolamine and Weight Loss
| Article | Year |
|---|---|
Two Cases of Thyrotoxicosis due to Redotex Ingestion, a Mexican Weight Loss Drug.
Topics: Adult; Atropine; Diazepam; Drug Combinations; Eating; Emodin; Female; Humans; Phenylpropanolamine; Thyrotoxicosis; Triiodothyronine; Weight Loss | 2021 |
The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction.
Topics: Animals; Appetite Depressants; Appetite Regulation; Biotransformation; Circadian Rhythm; Combined Modality Therapy; Diet, Fat-Restricted; Diet, High-Fat; Diet, Reducing; Diethylpropion; Drug Administration Schedule; Energy Intake; Half-Life; Injections, Intraperitoneal; Male; Overweight; Phenylpropanolamine; Rats, Sprague-Dawley; Weight Loss | 2016 |
Health risks, past usage, and intention to use weight loss products in normal weight women with high and low body dysphoria.
Topics: Adolescent; Adult; Advertising; Analysis of Variance; Appetite Depressants; Body Image; Body Mass Index; Cyclobutanes; Fat Substitutes; Fatty Acids; Female; Health Behavior; Humans; Intention; Mass Media; Phenylpropanolamine; Risk Factors; Somatoform Disorders; Sucrose; United States; Weight Loss | 2003 |
Comparative effectiveness of phenylpropanolamine and dextro amphetamine on weight reduction.
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Humans; Obesity; Phenylpropanolamine; Sympathomimetics; Weight Loss | 1959 |
Effects of phenylpropanolamine on regulatory and nonregulatory ingestion in adult rats.
Topics: Animals; Appetite; Arousal; Dose-Response Relationship, Drug; Drinking; Eating; Homeostasis; Hunger; Male; Phenylpropanolamine; Rats; Thirst; Weight Loss | 1993 |
Influence of a combination of herbs on appetite suppression and weight loss in rats.
Topics: Animals; Appetite Depressants; Appetite Regulation; Drug Combinations; Drugs, Chinese Herbal; Intubation, Gastrointestinal; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Weight Loss | 2001 |
Diet drug safe and effective.
Topics: Humans; Phenylpropanolamine; Weight Loss | 1991 |